USD/CAD: Double Breakdown Expected to Initiate Profit-Taking – 17 April 2020

Optimism on the prospects of Gilead Sciences’ remdesivir swelled after promising results of one Phase 3 trial were leaked,

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *